retatrutide phase 2 trial results obesity Effects of on body composition in people with type diabetes: a substudy of a 2, double-blind, parallel-group, placebo-controlled, randomised Retatrutide for Obesity: Phase 2

Among firms with 200 or more employees that offer health benefits, 41% say that providing employees with additional information about the cost of services will help their health care decision making a great deal, 38% of these firms say that it will help their decision making somewhat, 15% say that it will help their decision making very little, and 2% say that it will help their decision making not at all

Murphy-Rose warned me not to expect results right away

Licensed injectable GLP-1 receptor agonists such as semaglutide and dulaglutide are available for appropriate patients through NHS prescribing

Confident choices

Bakris GL, Agarwal R, Anker SD, et al

In recent years, a class of medications known as GLP-1 receptor agonists (GLP-1s) has gained tremendous attention